Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function

Journal of Hepatology

Volumn 30, Issue 1, 1999, Pages 142-148

  Plevris, John N ^a   Jalan, Rajiv ^a   Bzeizi, Khalid I ^a   Dollinger, Matthias M ^a   Lee, Alastair ^a   Garden, O James ^a   Hayes, Peter C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Indocyanine green clearance; Liver transplantation; Neutrophil elastase; Reactive oxygen intermediates

Indexed keywords

INDOCYANINE GREEN; LEUKOCYTE ELASTASE; REACTIVE OXYGEN METABOLITE; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG CLEARANCE; EARLY DIAGNOSIS; ENTEROHEPATIC CIRCULATION; FEMALE; GLUCOSE METABOLISM; GRAFT SURVIVAL; HUMAN; LIVER FUNCTION; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; REPERFUSION INJURY; SCORING SYSTEM;

EID: 0032922777     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80018-X     Document Type: Article

References (35)

1. Starzl T, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med. 321:1989;1014-1022.
2. Furukawa H, Todo S, Imventarza O, Starlz TE. Effects of cold ischaemia on the early outcome of human hepatic allografts preserved with UW solution. Transplantation. 5:1991;1000-1004.
3. Ludwig J. Histopathology of the liver following liver transplantation. Maddrey WC, . Transplantation of the Liver. 1988;191-218 Elsevier, New York.
4. Momii S, Koga A, Egushi M, Fukuyama T. Ultrastructural changes in rat liver sinusoids during storage in cold Euro-Collins solution. Virchows Arch. B27:1989;393-398.
5. Forster J, Greig PD, Glynn MFX, Poon A, Levy G, Superina A, et al. Coagulation factors as indicators of early graft function following liver transplantation. Transplant Proc. 21:1989;2308-2310.
6. Chazouilleres O, Calmus Y, Vaubourdolle M, Ballet F. Preservation-induced liver injury: clinical aspects, mechanisms, and therapeutic approaches. J Hepatol. 18:1993;123-124.
7. Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, et al. Treatment of primary graft function with prostaglandin E1. Transplantation. 48:1989;447-453.
8. Jalan R, Plevris JN, Jalan AR, Finlayson NDC, Hayes PC. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation. 58:1994;196-200.
9. Wheeler HO, Cranston WI, Meltzer JI. Hepatic uptake and biliary excretion of indocyanine green in the dog. Proc Soc Exp Biol Med. 99:1958;11-20.
10. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 21:1961;43-47.
11. Gilmore IT, Marigold JH, Thompson RPH. Half-life or clearance of indocyanine green in patients with liver disease. Hepatogastroenterology. 29:1982;55-57.
12. Iversen SA, Cawood P, Madigan MJ, Lawson AM, Dormandy TL. Identification of diene conjugated component of human lipid as octadeca-9,11 dienoic acid. FEBS Letts. 171:1984;320-324.
13. Iversen SA, Cawood P, Dormandy T.L. A method for the measurement of diene conjugated derivative of linoleic acid in serum phospholipid and possible origins. Ann Clin Biochem. 22:1985;137-140.
14. Plow EF. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. J Clin Invest. 69:1982;564-572.
15. Therapondos G, Peters CJ, Teig M, Stanley AJ, Plevris JN, Hayes PC. Near Infrared spectrometry measurement of indocyanine green elimination correlates with Child's -Pugh class in cirrhosis. Aliment Pharmacol Ther (in press).
16. Gonzalez FX, Rimola A, Grande L, Antolin M, Valdecas G, Fuster J, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology. 20:1994;565-573.
17. Nagel RA, Dirix LY, Hayllar KM, Preisig R, Tredger JM, Williams R. Use of quantitative liver function tests - caffeine clearance and galactose elimination capacity - after orthotopic liver transplantation. J Hepatol. 10:1990;149-157.
18. Svensson KL, Persson H, Henriksson BA, Karlberg I, Sonander H, Lundholm K, et al. Whole body gas exchange: amino acid and lactate clearance as indicators of initial and early allograft viability in liver transplantation. Surgery. 105:1989;472-480.
19. Ishigami Y, Masuzawa M, Miyoshi E, Kato M, Tamura K, Kanda M, et al. Clinical applications of ICG finger monitor in patients with liver disease. J Hepatol. 19:1993;232-240.
20. Hopton P, Phillips B, Walsh T, Plevris JN, Dollinger MM, Dawkes R, et al. Non-invasive measurement of indocyanine green elimination using cerebral near infrared spectroscopy. [abstract] Gut. 37:((S1)):1995;A223.
21. Shinohara H, Tanata A, Kitai T, Yanabu N, Inomoto T, Satoh S, et al. Direct measurement of hepatic indocyanine green clearance with near infrared spectroscopy; separate evaluation of uptake and removal. Hepatology. 23:1996;137-144.
22. Tsubono T, Todo S, Jabbour N, Mizoe A, Warty V, Demetris AJ, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology. 24:1996;1165-1171.
23. Koo A, Komatsu H, Tao G, Inoue M, Guth PH, Kaplowitz N. Contribution of no-reflow phenomenon to hepatic injury after ischaemia-reperfusion: evidence for a role for superoxide anion. Hepatology. 15:1992;507-514.
24. Bzeizi KI, Jalan R, Plevris JN, Hayes PC. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transplant Surg. 3:1997;137-148.
25. Engler RL, Dahlgren MD, Peterson MA, Dobbs A, Schmidschonbein GM. Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischaemia. Am J Physiol. 251:1986;H699-H703.
26. Kubes P, Ibbotson G, Russel, Wallace JL, Granger DN. Role of platelet activating factor in ischaemia reperfusion induced leukocyte adherence. Am J Physiol. 259:1990;G300-G305.
27. Parks DA, Granger DN. Ischaemia-induced microvascular changes: role of xanthine oxidase and hydroxyl radicals. Am J Physiol. 245:1983;G285-G289.
28. Arthus MJP. Reactive oxygen intermediates and liver injury. J Hepatol. 6:1988;125-131.
29. Bzeizi IK, Soutar A, Hayes PC. Free radical production following vascular reperfusion. Lancet. 342:1993;61-62.
30. Bzeizi IK, Dawkes R, Dodd NJF, Plevris JN, Hayes PC. Graft dysfunction following liver transplantation; role of free radicals. J Hepatol. 26:1997;69-74.
31. Janoff A. Elastase in tissue injury. Annu Rev Med. 36:1985;207-216.
32. Phan SH, Gannon DE, Ward PA, Karmiol S. Mechanism of neutrophil-induced xanthine dehydrogenase to xanthine oxidase conversion in endothelial cells: evidence of role for clastase. Am J Respir Cell Mol. Biol. 6:1992;270-278.
33. Bzeizi KI, Jalan R, MacGregor I, Drummond O, Lee A, Hayes PC. Neutrophil elastase; a determinant of endothelial damage and reperfusion injury after liver transplantation. Transplantation. 62:1996;916-920.
34. Lehr HA, Guhlmann N, Nolte D, Keppler D, Messmer K. Leukotrienes as mediators in ischaemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest. 87:1991;2036-2041.
35. Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, et al. Endothelin-1 is involved in the pathogenesis of ischaemia: reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology. 19:1994;675-681.